Ledger.Open graph →
SEC Form D · filed September 2, 2022

Jaguar Health, Inc

Offering
$12.0M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Steven King · San Francisco, CAExecAnula B. Jayasuriya · San Francisco, CADirectorCarol Lizak · San Francisco, CAExecJohn Micek Iii · San Francisco, CADirectorJames Bochnowski · San Francisco, CADirectorJonathan B. Siegel · San Francisco, CADirectorJonathan Wolin · San Francisco, CAExecLisa Conte · San Francisco, CAExec · DirectorDavid Jeffrey · London, United KingdomDirectorMichael Kramarz · New York, NYExecPeter J. Schreck · Boston, MADirectorBlake Dube · Pittsburgh, PAExec · DirectorEgen Atkinson · New York, NYExecMichael Mccormick · New York, NYDirectorMorton Wendell · New York, NYDirectorElyse E. Stock · Chapel Hill, NCDirectorGilles J. De Vignemont · Summit, NJExecPeter Henn · Farmington Hills, MIDirectorCraig E. Walters · Ft. Worth., TXExec · DirectorBrian T. Stevens · Farmington Hills, MIExecMichelle D. Spreitzer · Farmington Hills, MIExecCameron J. Keating · Ft. Worth., TXExecZiqiang Tang · Berkeley, CADirectorAnton Quiroz · Plano, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗